Korean Treatment Guideline on Pharmacotherapy of Co-existing Symptoms and Antipsychotics-related Side Effects in Patients with Schizophrenia.
Je Yeon Yun, Jung Suk Lee, Shi Hyun Kang, Beomwoo Nam, Seung Jae Lee, Seung Hwan Lee, Joonho Choi, Chan Hyung Kim, Young Chul Chung
Korean J Schizophr Res. 2019;22(2):21-33.   Published online 2019 Oct 31     DOI: https://doi.org/10.16946/kjsr.2019.22.2.21
Citations to this article as recorded by Crossref logo
Management of cardiovascular disease in patients with schizophrenia
Ji Hyun Baek
Journal of the Korean Medical Association.2024; 67(2): 115.     CrossRef
Antipsychotic treatment and risk of discontinuation and hospitalization in first-episode schizophrenia: a nationwide population-based study
Sung Woo Joo, Harin Kim, Young Tak Jo, Young Jae Choi, Soojin Ahn, Jungsun Lee
Psychological Medicine.2023; 53(1): 181.     CrossRef
Breakthrough Psychosis and Long-Acting Injectable Antipsychotics
Eun-Jeong Joo, Kyu Young Lee, Seong Hoon Jeong, Yong Sik Kim
Korean Journal of Schizophrenia Research.2023; 26(1): 1.     CrossRef
Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process
Hye Ri Kim, Sun Mi Kim, Won Sub Kang, Hong Jun Jeon, Seung-Ho Jang, Duk-In Jon, Jeongwan Hong, Jong-Hyun Jeong
Clinical Psychopharmacology and Neuroscience.2023; 21(3): 447.     CrossRef
Change of Prescribing Pattern after Clozapine Discontinuation: A Retrospective Chart Review
Shi Hyun Kang
Korean Journal of Schizophrenia Research.2021; 24(1): 36.     CrossRef